Pancreatic manifestations of von Hippel-Lindau disease

Archives of Pathology and Laboratory Medicine

Volumn 134, Issue 7, 2010, Pages 1080-1083

  Safo, Anthony Osei F ^a   Pambuccian, Stefan E ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DIFFERENTIAL DIAGNOSIS; GENETIC PREDISPOSITION; GENETICS; HUMAN; METASTASIS; PANCREAS TUMOR; PATHOLOGY; PENETRANCE; PROGNOSIS; VON HIPPEL LINDAU DISEASE;

DIAGNOSIS, DIFFERENTIAL; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PANCREATIC NEOPLASMS; PENETRANCE; PROGNOSIS; VON HIPPEL-LINDAU DISEASE;

EID: 77954346056     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. von Hippel E. Die anatomische Grundlage der von mir beschriebenen "sehr seltene Erkrankung der Netzhaut." A von Graefe's Arch Ophthalmol. 1911;79:350-377.
2. Lindau A. Studien uber kleinhirnzysten: bau, pathogenese und beziehungen zur angiomatosis retinae. Acta Pathol. Microbiol Scand Suppl. 1926;1(suppl. II): 1-128.
3. Melmon KL, Rosen SW. Lindau's disease: review of the literature and study of a large kindred. Am J Med. 1964;36:595-617.
4. Lonser RR, Glenn GM, Walther M, et al. Von Hippel-Lindau disease. Lancet. 2003;361(9374):2059-2067.
5. Woodward ER, Maher ER. Von Hippel-Lindau disease and endocrine tumour susceptibility. Endocr Relat Cancer. 2006;13(2):415-425.
6. Seizinger BR, Rouleau GA, Ozelius LJ, et al. Von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma. Nature. 1988;332(6161):268-269.
7. Latif F, Tory K, Gnarra J, et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science. 1993;260(5112):1317-1320. (Pubitemid 23231974)
8. Duan DR, Humphrey JS, Chen DY, et al. Characterization of the VHL tumor suppressor gene product: localization, complex formation, and the effect of natural inactivating mutations. Proc Natl Acad Sci U S A. 1995;92(14):6459-6463.
9. Maxwell PH, Wiesener MS, Chang GW, et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature. 1999;399(6733):271-275.
10. Pause A, Lee S, Lonergan KM, Klausner RD. The von Hippel-Lindau tumor suppressor gene is required for cell cycle exit upon serum withdrawal. Proc Natl Acad Sci U S A. 1998;95(3):993-998.
11. Bohling T, Hatva E, Kujala M, Claesson-Welsh L, Alitalo K, Haltia M. Expression of growth factors and growth factor receptors in capillary hemangioblastoma. J Neuropathol Exp Neurol. 1996;55(5):522-527. (Pubitemid 26140834)
12. Knudson AG Jr. Hereditary cancer, oncogenes, and antioncogenes. Cancer Res. 1985;45(4):1437-1443.
13. Stolle C, Glenn G, Zbar B, et al. Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene. Hum Mutat. 1998;12(6):417-423.
14. Sano T, Horiguchi H. Von Hippel-Lindau disease. Microsc Res Tech. 2003;60(2):159-164.
15. Mukhopadhyay B, Sahdev A, Monson JP, Besser GM, Reznek RH, Chew SL. Pancreatic lesions in von Hippel-Lindau disease. Clin Endocrinol (Oxf). 2002;57(5):603-608.
16. Wanebo JE, Lonser RR, Glenn GM, Oldfield EH. The natural history of hemangioblastomas of the central nervous system in patients with von Hippel-Lindau disease. J Neurosurg. 2003;98(1):82-94.
17. Corcos O, Couvelard A, Giraud S, et al. Endocrine pancreatic tumors in von Hippel-Lindau disease: clinical, histological, and genetic features. Pancreas. 2008;37(1):85-93.
18. Delman KA, Shapiro SE, Jonasch EW, et al. Abdominal visceral lesions in von Hippel-Lindau disease: incidence and clinical behavior of pancreatic and adrenal lesions at a single center. World J Surg. 2006;30(5):665-669.
19. Lubensky IA, Pack S, Ault D, et al. Multiple neuroendocrine tumors of the pancreas in von Hippel-Lindau disease patients: histopathological and molecular genetic analysis. Am J Pathol. 1998;153(1):223-231.
20. Hoang MP, Hruban RH, Albores-Saavedra J. Clear cell endocrine pancreatic tumor mimicking renal cell carcinoma: a distinctive neoplasm of von Hippel-Lindau disease. Am J Surg Pathol. 2001;25(5):602-609. (Pubitemid 32423357)
21. Safo AO, Li RW, Vickers SM, Schmechel SC, Pambuccian SE. Endoscopic ultrasound-guided fine-needle aspiration diagnosis of clear-cell pancreatic endocrine neoplasm in a patient with von Hippel-Lindau disease:: a case report. Diagn Cytopathol. 2010;37(5):365-372.
22. Virlos I, Papazachariou I, Wiliamson R. Acinar cell carcinoma of the pancreas with and without endocrine differentiation. HPB (Oxford). 2002;4(2):87-90.
23. Klimstra DS, Wenig BM, Heffess CS. Solid-pseudopapillary tumor of the pancreas: a typically cystic carcinoma of low malignant potential. Semin Diagn Pathol. 2000;17(1):66-80.
24. Santini D, Poli F, Lega S. Solid-papillary tumors of the pancreas: histopathology. JOP. 2006;7(1):131-136.
25. Serra S, Chetty R. Revision 2: an immunohistochemical approach and evaluation of solid pseudopapillary tumour of the pancreas. J Clin Pathol. 2008;61(11):1153-1159.
26. Kogire M, Hosotani R, Kondo M, et al. Pancreatic lesions in von Hippel-Lindau syndrome: the coexistence of metastatic tumors from renal cell carcinoma and multiple cysts. Surg Today. 2000;30(4):380-382.
27. Ling H, Cybulla M, Schaefer O, Arnold C, Schories M, Neumann HP. When to look for Von Hippel-Lindau disease in gastroenteropancreatic neuroendocrine tumors? Neuroendocrinology. 2004;80 Suppl: 139-146.
28. Lin F, Shi J, Liu H, et al. Diagnostic utility of S100P and von Hippel-Lindau gene product (pVHL) in pancreatic adenocarcinoma-with implication of their roles in early tumorigenesis. Am J Surg Pathol. 2008;32(1):78-91.
29. Hammel PR, Vilgrain V, Terris B, et al. Pancreatic involvement in von Hippel-Lindau disease. Gastroenterology. 2000;119(4):1087-1095.
30. Libutti SK, Choyke PL, Alexander HR, et al. Clinical and genetic analysis of patients with pancreatic neuroendocrine tumors associated with von Hippel-Lindau disease. Surgery. 2000;128(6):1022-1027; discussion 1027-1028.